IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 222 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $15,652,000 | -72.3% | 1,510,792 | -69.2% | 0.03% | -70.3% |
Q2 2022 | $56,511,000 | -6.2% | 4,901,198 | +2.3% | 0.10% | +11.0% |
Q1 2022 | $60,273,000 | +27.0% | 4,791,196 | +17.7% | 0.09% | +33.8% |
Q4 2021 | $47,471,000 | -33.7% | 4,071,262 | -25.8% | 0.07% | -38.7% |
Q3 2021 | $71,615,000 | +17.5% | 5,483,569 | +15.8% | 0.11% | +16.8% |
Q2 2021 | $60,971,000 | +62.9% | 4,737,415 | +41.5% | 0.10% | +53.2% |
Q1 2021 | $37,437,000 | -1.8% | 3,348,532 | 0.0% | 0.06% | -8.8% |
Q4 2020 | $38,140,000 | +102.4% | 3,348,532 | +59.8% | 0.07% | +83.8% |
Q3 2020 | $18,848,000 | -3.5% | 2,095,332 | +10.7% | 0.04% | -11.9% |
Q2 2020 | $19,537,000 | +7.0% | 1,893,132 | +4.6% | 0.04% | -12.5% |
Q1 2020 | $18,256,000 | +382.8% | 1,809,332 | +423.5% | 0.05% | +500.0% |
Q2 2019 | $3,781,000 | +55.3% | 345,600 | +162.1% | 0.01% | +60.0% |
Q3 2018 | $2,434,000 | -66.3% | 131,858 | -65.1% | 0.01% | -37.5% |
Q2 2018 | $7,228,000 | – | 378,092 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HealthInvest Partners AB | 1,520,000 | $19,562,000 | 18.54% |
Sarissa Capital Management LP | 16,390,000 | $210,939,000 | 16.77% |
Healthcare Value Capital, LLC | 200,000 | $2,574,000 | 5.13% |
Camber Capital Management LP | 7,500,000 | $96,525,000 | 3.25% |
13D Management LLC | 650,455 | $8,371,000 | 2.88% |
BRIDGER MANAGEMENT, LLC | 2,035,114 | $26,192,000 | 2.44% |
Brown Capital Management | 18,484,759 | $237,899,000 | 1.80% |
Healthcare Value Capital, LLC | 50,000 | $644,000 | 1.28% |
Zebra Capital Management LLC | 53,359 | $687,000 | 0.80% |
PRICE MICHAEL F | 520,000 | $6,692,000 | 0.74% |